Navient Reports Q3 2025 Earnings Results

Navient (NAVI) reported strong Q3 2025 earnings with 6% constant currency revenue growth, driven by its base business and innovative products. The company highlighted growth in its pharmaceuticals segment, particularly from Miebo revenue, and noted 27% growth in premium intraocular lenses. The CEO emphasized the company's strategic focus on selling, operational, and innovation excellence.

By Motley Fool Transcribing, The Motley Fool Tue, April 21, 2026 at 6:41 PM GMT+3 · Yahoo Finance · April 21, 2026, 15:41 UTC

Tickers: $NAVI

Topics: Company Strategy Earnings Call Pipeline Development Product Launches Revenue Growth

Read the full article at Yahoo Finance

More World news

Nvidia Shares Decline Following Resignation of CEO Jensen Huang Seeking Alpha · November 12, 2026, 16:07 UTC
Broadcom and Micron Identified as Top Alternatives to Nvidia Amid Leadership Uncertainty Motley Fool · November 12, 2026, 16:03 UTC
Thomson Reuters Executives to Present at TD Securities Technology Conference PR Newswire · November 12, 2026, 16:00 UTC
BHP to Restructure Australian Iron Ore Operations Amid Rising Costs Seeking Alpha · November 12, 2026, 15:59 UTC
Capri Investment Group and GRIT Chicago Unveil $10 Billion Bronzeville Lakefront Development Plan PR Newswire · November 12, 2026, 16:00 UTC
Whoop Launches 'Whoop Humans' Social Network to Enhance Health Data Sharing TechCrunch · November 12, 2026, 16:00 UTC
SchoolWise Partners Advises on Sale of Wyalusing Valley and Wysox Children's Centers PR Newswire · November 12, 2026, 15:57 UTC
Jensen Huang Resigns as Nvidia CEO Amid Personal Scandal and Leadership Crisis CNBC · November 12, 2026, 15:45 UTC
Keurig Dr Pepper Launches $2 Billion Equity Offering to Reduce Debt Ahead of Corporate Split Seeking Alpha · November 12, 2026, 15:51 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC